$4.51
-0.260 (-5.45%)
At Close: Jun 03, 2026
Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate
07:30am, Monday, 09'th Dec 2024
BEIJING , Dec. 9, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, edu
Concord Medical Schedules 2024 Annual Meeting of Shareholders
08:00am, Wednesday, 13'th Nov 2024
BEIJING , Nov. 13, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, edu
Concord Medical Reports Financial Results for the First Half of 2024
07:00am, Friday, 27'th Sep 2024
BEIJING , Sept. 27, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, ed
Canagold Completes Resource Expansion Drilling Program at New Polaris with Additional Strong Mineralization Intercepts
07:30am, Wednesday, 18'th Sep 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM #drilling--Canagold Resources Ltd. (“Canagold” or the “Company”) (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) announces sample assay results
Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment
08:00am, Monday, 16'th Sep 2024
BEIJING , Sept. 16, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, e
Concord Medical Regains Compliance with NYSE Minimum Price Requirement
08:30am, Wednesday, 07'th Aug 2024
BEIJING , Aug. 7, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, edu
CONCORD MEDICAL ANNOUNCES PLAN TO IMPLEMENT ADS RATIO CHANGE
04:00pm, Thursday, 11'th Jul 2024
BEIJING , July 11, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, edu
Canagold Resources Ltd. Announces Voting Results From Annual General Meeting
06:05pm, Thursday, 13'th Jun 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (the “Company”) announces that at its annual general meeting o
Canagold Initiates Resource Expansion Drilling at New Polaris Project
07:30am, Wednesday, 05'th Jun 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (the “Company” or “Canagold”), is pleased to announce that
Concord Medical Files 2023 Annual Report on Form 20-F
08:31am, Friday, 19'th Apr 2024
BEIJING , April 19, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, ed
Canagold Resources Ltd. Announces Closing of $4.1M Charity Flow Through Financing
03:38pm, Thursday, 28'th Mar 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (the "Company" or "Canagold"), is pleased to announce it has close
Concord Medical Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price
07:00am, Tuesday, 20'th Feb 2024
BEIJING , Feb. 20, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, ed
Concord Medical Announces Listing of Its Subsidiary on The Stock Exchange of Hong Kong Limited
07:00am, Tuesday, 09'th Jan 2024
BEIJING , Jan. 9, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, edu
Canagold Appoints Chris Pharness as Senior Vice President Sustainability and Permitting
07:30am, Thursday, 04'th Jan 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (“Canagold” or the “Company”) announces today that the Com
Concord Medical Schedules 2023 Annual Meeting of Shareholders
04:00pm, Monday, 20'th Nov 2023
BEIJING , Nov. 20, 2023 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, edu
Sign In
Buy CCM